The Breakthrough Summit is just under two weeks away, and we're thrilled to unveil the final agenda, including sessions with distinguished leaders from Gilead Sciences and Verily as well as experts from prestigious institutions like Harvard, NYU, and U Penn.
Don't miss out on this amazing opportunity to participate either virtually or in person in San Francisco by registering now.
Get Ticket
Get ready for an insightful series of conversations featuring dynamic speakers from every corner of health and medicine, including:
Do Viruses Cause Alzheimer's?
One of the biggest scientific advances of 2022 was the realization that MS may be caused by a common viral infection. What other diseases might actually be caused by viral infection? Two candidates: Alzheimer's and ALS.
- Alberto Ascherio, M.D., Dr.PH, Professor of Epidemiology and Nutrition, Harvard TH Chan School of Public Health
- Ruth Itzhaki, Ph.D., Visiting Professorial Fellow, University of Oxford; Professorial Fellow Emerita, University of Manchester
Biotech After SVB
The collapse of SVB and a sluggish IPO market spell uncertainty for biotech companies. Hear from a group of leading investors and startup founders about what comes next for one of the most important engines of biomedical innovation.
- Vineeta Agarwala, M.D., Ph.D., General Partner, Andreessen Horowitz
- Paul Hastings, Chief Executive Officer and President, Nkarta
- Camille Samuels, Partner, Venrock
- Surbhi Sarna, Group Partner, Y Combinator
The New Obesity Treatments: Benefits and Risks
New medicines are having a substantial impact on obesity. They promise to improve and maybe even save people's lives. But do they also pose risks? How do we get the most out of these drugs?
- Jamy Ard, M.D., Professor, Wake Forest School of Medicine; Co-director, Weight Management Center, Atrium Health Wake Forest Baptist
- Robert Lustig, M.D., MSL, Emeritus Professor of Pediatrics, UCSF
Register now and check out statnews.com/summit to explore the full agenda and meet featured speakers. We hope to see you there - virtually or in person - in May!
No comments